Date Posted: June 25, 2026

This Billing and Coding Article has been revised under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: Multiple dates

Summary of Changes:

Under Article Text revised Table 1 row 3 to add "NeXT Personal - Personalized WGS Assay Design + Plasma Series Bundle (Personalis, Inc)". Under subheading Additional Test-specific Indications, Limitations and Instructions revised 3rd sentence to add "or stage IV (NeXT Personal)". This revision is due to a new covered test that has successfully completed a TA and is effective for 3/16/2026.

Under Article Text revised Table 1 row 9 to add "TrueMRD Assay Design + single Plasma Test (Veracyte, Inc)". Revised Table 1 row 10 to add "TrueMRD single Plasma Test (Veracyte, Inc)". Under subheading Additional Test-specific Indications, Limitations and Instructions revised 2nd sentence to add "and muscle invasive bladder cancer (TrueMRD)". This revision is due to a new covered test that has successfully completed a TA and is effective for 11/24/2025.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.